How to explain an FDA inspection to your board or investors
After an inspection, leaders often want a simple verdict. The accurate briefing starts with the documents that actually exist and keeps their meanings separate.
Identify the record and its scope
State the inspected site, activity, dates, and documents available for review. FDA explains that a Form 483 records inspectional observations and is not a final agency determination. Do not call a Form 483 a warning letter, a final classification, or a complete list of every possible issue.
Use a fact–response–evidence structure
For each issue being briefed, distinguish the observation from management’s assessment, the action taken or proposed, and the evidence available to support the response. Identify open questions and dependencies. If a later official communication exists, read it directly rather than infer its contents from an earlier document.
Present uncertainty without speculation
A useful working table can include the source, question, responsible owner, current evidence, unresolved point, and next review. This keeps an anticipated action separate from a completed one. Avoid forecasts of agency action or financial impact unless they have an appropriate, documented basis and authorized review.
Coordinate who communicates
Agree the audience, purpose, confidentiality boundaries, and approval process with the relevant quality, legal, regulatory, and disclosure advisers. Keep the external message consistent with the underlying records. A reassuring phrase should never replace a supported explanation.
Use the free response-planning worksheet for internal preparation, then obtain advice suited to the actual inspection and communication context.
Source context, reviewed October 20, 2026: Official FDA or eCFR reference. The working methods and discussion prompts in this article are independent preparation suggestions, not an official agency checklist or a complete statement of applicable obligations.
Related decisions and learning
Buying a regulated business · Briefing your board · Investor communication · Fractional QA · Short guides · Proposed training